Abstract
Stereotactic body radiation therapy (SBRT) combines the latest advancements in image guidance, planning, and treatment delivery to direct tumoricidal doses to the target. This is accomplished with acceptable sparing of normal tissues which was not practical or feasible with traditional techniques. Over the last decade, SBRT is evolving and in some areas has been established as the contemporary standard of care. This is especially the case in inoperable non-small cell lung cancers, where it has emerged as highly effective with successful results that have been reproduced around the world. Several other applications of SBRT require continued studies and careful design of additional prospective studies. The technique demands the latest developments in patient immobilization, dosimetry planning, and delivery of the intended dose to the target using near real-time imaging and precise assessment of expected tumor motion during the treatment. In addition, dosimetric parameters must spare a significant portion of functional subunits in the adjacent normal tissues. A careful consideration in selection of eligible patients cannot be stressed enough. Increased efficacy combined with convenient fractionation schedule remains highly attractive for patients. Long-term results with favorable outcomes with similar or reduced treatment-related morbidity will further accelerate the acceptance of SBRT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al Hamad AA, Hassanain M et al (2009) Stereotactic radiotherapy of the liver: a bridge to transplantation stereotactic radiotherapy of the liver: a bridge to transplantation. Technol Cancer Res Treat 8(6):401–405
Aluwini S, van Rooij P et al (2010) CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance. J Endourol 24(5):865–869
Andrews DW, Scott CB et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363(9422):1665–1672
Armstrong JG, Minsky BD (1989) Radiation therapy for medically inoperable stage I and II non-small cell lung cancer. Cancer Treat Rev 16(4):247–255
Baba F, Shibamoto Y et al (2010) Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 5(1):81
Barnes M, Pass H et al (1987) Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy (IORT). Int J Radiat Oncol Biol Phys 13(3):371–378
Bates T (1992) A review of local radiotherapy in the treatment of bone metastases and cord compression. Int J Radiat Oncol Biol Phys 23(1):217–221
Baumann P, Nyman J et al (2006) Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45(7):787–795
Baumann P, Nyman J et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27(20):3290–3296
Beitler JJ, Makara D et al (2004) Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 27(6):646–648
Benedict SH, Lin PS et al (1997) The biological effectiveness of intermittent irradiation as a function of overall treatment time: development of correction factors for linac-based stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 37(4):765–769
Bergonie J, Tribondeau L (1906) Interpretation de quelques resultats de la radiotherapie et essai de fixaation d’une technique rationelle. Compt Rend Acad Sci Paris 143:983–985
Blomgren H, Lax I et al (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34(6):861–870
Blomgren H, Lax I et al (1998) Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1(1):63–74
Blumgart LH, Fong Y (1995) Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 32(5):333–421
Borgelt BB, Gelber R et al (1981) The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 7(5):587–591
Bral S, Gevaert T et al (2010) prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial. Int J Radiat Oncol Biol Phys (in press, corrected proof)
Brenner DJ, Hall EJ (1999) Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43(5):1095–1101
Brown WT, Wu X et al (2007) CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Clin Lung Cancer 8(8):488–492
Cardenes HR (2009) Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results. Clin Transl Oncol 11(5):276–283
Cardenes HR, Price TR et al (2010) Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol 12(3):218–225
Chan DY, Koniaris L et al (2000) Feasibility of ablating normal renal parenchyma by interstitial photon radiation energy: study in a canine model. J Endourol 14(2):111–116
Chang EL, Shiu AS et al (2007) Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151–160
Cheng JC, Liu HS et al (2005) Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys 62(4):1150–1156
Choi BO, Jang HS et al (2006) Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol 36(3):154–158
Choi BO, Choi IB et al (2008) Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer 8:351
Coutard H (1924) Note preliminaire sur la radiographic du larynx normal et du larynx cancereux. J Belge Radiol 13:487–490
Coutard H (1929) Die Roentgenbehandlung des epithelialen Krebse der Ton-sillengegund. Strahlentherapie 33:249–252
Coutard H (1930) Resume des principes de technique roentgentherapic des. Radiophys Radiother 2:376–383
Coutard H (1932) Roentgentherapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926. Am J Roentgenol 28:313–331
Curley SA, Izzo F et al (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230(1):1–8
Curtis SB (1986) Lethal and potentially lethal lesions induced by radiation—a unified repair model. Radiat Res 106(2):252–270
Dawood O, Mahadevan A et al (2009) Stereotactic body radiation therapy for liver metastases. Eur J Cancer 45(17):2947–2959
Dawson LA, Ten Haken RK (2005) Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15(4):279–283
Dawson LA, Normolle D et al (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53(4):810–821
Dawson LA, Eccles C et al (2006) Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45(7):856–864
Dessauer F (1921) My studies on the special foundations of deep therapy treatment. Am J Roentgenol 8:578–588
Donckier V, Van Laethem JL et al (2003) [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84(4):215–223
Dosoretz DE, Galmarini D et al (1993) Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 27(3):507–516
Dosoretz DE, Katin MJ et al (1996) Medically inoperable lung carcinoma: the role of radiation therapy. Semin Radiat Oncol 6(2):98–104
Dunlap NE, Cai J et al (2010) Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):796–801
Emami B, Lyman J et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21(1):109–122
Fakiris AJ, McGarry RC et al (2009) Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75(3):677–682
Forquer JA, Fakiris AJ et al (2009) Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 93(3):408–413
Fowler J, Chappell R et al (2001) Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50(4):1021–1031
Friedland JL, Freeman DE et al (2009) Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 8(5):387–392
Fritz P, Kraus HJ et al (2006) Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 1:30
Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor response. Cancer Cell 8(2):89–91
Fuller DB, Naitoh J et al (2008) Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 70(5):1588–1597
Garcia-Barros M, Paris F et al (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622):1155–1159
Gerszten PC, Burton SA et al (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 32(2):193–199
Gillette SL, Gillette EL et al (1989) Ureteral injury following experimental intraoperative radiation. Int J Radiat Oncol Biol Phys 17(4):791–798
Ginsberg RJ, Rubinstein LV (1995) Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg 60(3):615–622 discussion 622–3
Goodman K, Wiegner E et al (2010) Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78(2):486–493
Guerrero M, Li XA (2004) Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 49(20):4825–4835
Haffty BG, Goldberg NB et al (1988) Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15(1):69–73
Hara R, Itami J et al (2006) Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 106(6):1347–1352
Henderson MA, Hoopes DJ et al (2010) A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):789–795
Herfarth KK, Debus J et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19(1):164–170
Herfarth KK, Debus J et al (2004) Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100–105
Hof H, Herfarth KK et al (2003) Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56(2):335–341
Hoogeman MS, Nuyttens JJ et al (2008) Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging. Int J Radiat Oncol Biol Phys 70(2):609–618
Hoopes DJ, Tann M et al (2007) FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56(2):229–234
Hoppe BS, Laser B et al (2008) Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys 72(5):1283–1286
Hoskin PJ, Price P et al (1992) A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain. Radiother Oncol 23(2):74–78
Hoyer M, Roed H et al (2006) Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45(7):823–830
Jackson A, Ten Haken RK et al (1995) Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31(4):883–891
Jeremic B, Shibamoto Y et al (1998) A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 42(1):161–167
Jin R, Rock J et al (2009) Single fraction spine radiosurgery for myeloma epidural spinal cord compression. J Exp Ther Oncol 8(1):35–41
Kaskowitz L, Graham MV et al (1993) Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27(3):517–523
Katz AW, Carey-Sampson M et al (2007) Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 67(3):793–798
Katz AJ, Santoro M et al (2010) Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 10:1
Kavanagh BD, Timmerman RD et al (2003) How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys 30(3):321–324
Kavanagh BD, Schefter TE et al (2006) Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45(7):848–855
Kelly H, Goldberg RM (2005) Systemic therapy for metastatic colorectal cancer: current options, current evidence. J Clin Oncol 23(20):4553–4560
Kelsey CR, Schefter T et al (2005) Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy. Am J Clin Oncol 28(6):576–580
Kemeny N (2006) Management of liver metastases from colorectal cancer. Oncology (Williston Park) 20(10):1161–1176 1179; discussion 1179–80, 1185–6
Kim TH, Kim DY et al (2007) Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67(1):225–231
Kim MS, Yoo SY et al (2009) Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology 76(3):212–219
King CR, Brooks JD et al (2009) Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 73(4):1043–1048
Kirkpatrick JP, van der Kogel AJ et al (2010) Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 76(Suppl 3):S42–S49
Koto M, Takai Y et al (2007) A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 85(3):429–434
Lawrence TS, Ten Haken RK et al (1992) The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23(4):781–788
Lee SW, Choi EK et al (2003) Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40(3):309–315
Lee MT, Kim JJ et al (2009a) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591
Lee Y, Auh SL et al (2009b) Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 114(3):589–595
Leibel SA, Pajak TF et al (1987) A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 13(7):1057–1064
Leksell L (1951) The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102(4):316–319
Liang SX, Zhu XD et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65(2):426–434
Linda A, Trovo M et al (2009) Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur J Radiol
Lo SS, Fakiris AJ et al (2009) In regard to Hoppe et al. (Int J Radiat Oncol Biol Phys 2008;72:1283–1286). Int J Radiat Oncol Biol Phys 74(3):977 author reply 978
Lo SS, Fakiris AJ et al (2010) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7(1):44–54
Lochan R, White SA et al (2007) Liver resection for colorectal liver metastasis. Surg Oncol 16(1):33–45
Ma L, Sahgal A et al (2009) Nonrandom intrafraction target motions and general strategy for correction of spine stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 75(4):1261–1265
Madsen BL, Hsi RA et al (2003) Intrafractional stability of the prostate using a stereotactic radiotherapy technique. Int J Radiat Oncol Biol Phys 57(5):1285–1291
Madsen BL, Hsi RA et al (2007) Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67(4):1099–1105
McGarry RC, Song G et al (2002) Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest 121(4):1155–1158
McGarry RC, Papiez L et al (2005) Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63(4):1010–1015
Mendez Romero A, Wunderink W et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol 45(7):831–837
Milano MT, Katz AW et al (2008a) A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 112(3):650–658
Milano MT, Katz AW et al (2008b) Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 72(5):1516–1522
Miralbell R, Molla M et al (2009) Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study. Int J Radiat Oncol Biol Phys 78(1):50–57
Morgia G, De Renzis C (2009) CyberKnife in the treatment of prostate cancer: a revolutionary system. Eur Urol 56(1):40–42
Moulding HD, Elder JB et al (2010) Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J Neurosurg Spine 13(1):87–93
Murphy MJ (2009) Intrafraction geometric uncertainties in frameless image-guided radiosurgery. Int J Radiat Oncol Biol Phys 73(5):1364–1368
Nagata Y, Negoro Y et al (2002) Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52(4):1041–1046
Nagata Y, Takayama K et al (2005) Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63(5):1427–1431
Nagata Y, Hiraoka M et al (2010) A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403). Int J Radiat Oncol Biol Phys 78(3 Suppl 1):S27–S28
Nesbitt JC, Putnam JB Jr et al (1995) Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 60(2):466–472
Nguyen QN, Shiu AS et al (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185–1192
Norihisa Y, Nagata Y et al (2008) Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 72(2):398–403
Onimaru R, Shirato H et al (2003) Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56(1):126–135
Onishi H, Araki T et al (2004) Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101(7):1623–1631
Pan CC, Kavanagh BD et al (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S94–S100
Park C, Papiez L et al (2008) Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70(3):847–852
Parkin DM, Bray FI et al (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4–S66
Pennathur A, Luketich JD et al (2007) Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience. Ann Thorac Surg 83(5):1820–1824 discussion 1824–5
Ponsky LE, Crownover RL et al (2003) Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation. Urology 61(3):498–501
Potters L, Gaspar LE et al (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). Int J Radiat Oncol Biol Phys 76(2):319–325
Rades D, Freundt K et al (2010) Dose escalation for metastatic spinal cord compression in patients with relatively radioresistant tumors. Int J Radiat Oncol Biol Phys. [Epub ahead of print: June 23, 2010]
Raz DJ, Zell JA et al (2007) Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 132(1):193–199
Ricardi U, Guarneri A et al (2007) Stereotactic body radiation therapy for early non-small cell lung cancer: experience at the University of Turin. J Thorac Oncol 2(5 Suppl):S47
Ricardi U, Filippi AR et al (2010) Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. Lung Cancer 68(1):72–77
RTOG (2010) “A randomized phase II study comparing 2 Stereotactic Body Radiation Therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.” http://www.rtog.org/members/active.html
Rusthoven KE, Kavanagh BD et al (2009a) Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 27(10):1579–1584
Rusthoven KE, Kavanagh BD et al (2009b) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578
Ryu S, Jin R et al (2008) Pain control by image-guided radiosurgery for solitary spinal metastasis. J Pain Symptom Manage 35(3):292–298
Sahgal A, Ma L et al (2010) Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 77(2):548–553
Sandroussi C, Dawson LA et al (2009) Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma. Transpl Int 23(3):299–306
Sato M, Uematsu M et al (1998) Feasibility of frameless stereotactic high-dose radiation therapy for primary or metastatic liver cancer. J Radiosurg 1(3):233–238
Schefter TE, Kavanagh BD et al (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62(5):1371–1378
Scorsetti M, Navarria P et al (2007) Effectiveness of stereotactic body radiotherapy in the treatment of inoperable early-stage lung cancer. Anticancer Res 27(5B):3615–3619
Sheehan JP, Shaffrey CI et al (2009) Radiosurgery in the treatment of spinal metastases: tumor control, survival, and quality of life after helical tomotherapy. Neurosurgery 65(6):1052–1061 discussion 1061–2
Sindelar WF, Tepper J et al (1982) Tolerance of bile duct to intraoperative irradiation. Surgery 92(3):533–540
Sindelar WF, Hoekstra HJ et al (1988) Response of canine esophagus to intraoperative electron beam radiotherapy. Int J Radiat Oncol Biol Phys 15(3):663–669
Small R, Lubezky N et al (2007) Current controversies in the surgical management of colorectal cancer metastases to the liver. Isr Med Assoc J 9(10):742–747
Solbiati L, Livraghi T et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221(1):159–166
Specified NA (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 113(1):37–49
Svedman C, Karlsson K et al (2008) Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol 47(8):1578–1583
Sze WM, Shelley M et al (2004) Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy—a systematic review of the randomised trials. Cochrane Database Syst Rev 2:CD004721
Takeda A, Takahashi M et al (2008) Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: preliminary results for efficacy and toxicity. Hepatol Res 38(1):60–69
Teh BS (2007) The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J 3:e6
Tepper JE, Sindelar W et al (1983) Tolerance of canine anastomoses to intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 9(7):987–992
Timmerman R, Papiez L et al (2003) Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124(5):1946–1955
Timmerman RD, Forster KM et al (2005) Extracranial stereotactic radiation delivery. Semin Radiat Oncol 15(3):202–207
Timmerman R, McGarry R et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24(30):4833–4839
Timmerman RD, Park C et al (2007) The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2(7 Suppl 3):S101–S112
Timmerman R, Paulus R et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama 303(11):1070–1076
Trovo M, Linda A et al (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69(1):77–85
Tse RV, Hawkins M et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26(4):657–664
Uematsu M, Shioda A et al (1998) Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82(6):1062–1070
Uematsu M, Shioda A et al (2001) Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51(3):666–670
Vahdat S, Oermann E et al (2010) CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment. J Hematol Oncol 3(1):6
Voroney JP, Hope A et al (2009) Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. J Thorac Oncol 4(8):1035–1037
Wada H, Takai Y et al (2004) Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 58(4):1114–1120
Wang L, Jacob R et al (2004) Stereotactic IMRT for prostate cancer: setup accuracy of a new stereotactic body localization system. J Appl Clin Med Phys 5(2):18–28
Wang JZ, Huang Z et al (2010a) A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med 2(39):39–48
Wang MH, Ji Y et al (2010b) Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume. Int J Radiat Oncol Biol Phys 76(2):467–476
Wersall PJ, Blomgren H et al (2005) Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 77(1):88–95
Wiegner EA, King CR (2010) Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial. Int J Radiat Oncol Biol Phys 78:442–448
Wu JS, Wong R et al (2003) Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55(3):594–605
Wu QJ, Yoo S et al (2009) Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. Int J Radiat Oncol Biol Phys 75(5):1596–1604
Wulf J, Hadinger U et al (2001) Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177(12):645–655
Wulf J, Haedinger U et al (2004) Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60(1):186–196
Wulf J, Guckenberger M et al (2006) Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 45(7):838–847
Wurm RE, Gum F et al (2006) Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: initial experience. Acta Oncol 45(7):881–889
Xu ZY, Liang SX et al (2006) Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65(1):189–195
Yamada Y, Bilsky MH, Lovelock DM (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71:484–490
Zimmermann FB, Geinitz H et al (2005) Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48(1):107–114
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Cho, L.C., Fonteyne, V., DeNeve, W., Lo, S.S., Timmerman, R.D. (2011). Stereotactic Body Radiotherapy. In: Levitt, S., Purdy, J., Perez, C., Poortmans, P. (eds) Technical Basis of Radiation Therapy. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_263
Download citation
DOI: https://doi.org/10.1007/174_2011_263
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11571-4
Online ISBN: 978-3-642-11572-1
eBook Packages: MedicineMedicine (R0)